5436352026-08-185436352026-08-182026-08-185436352026-08-18in-capmkt:FinancialYear1Member5436352026-08-18in-capmkt:FinancialYear2Member5436352026-08-18in-capmkt:FinancialYear3Member5436352026-08-182026-08-18in-capmkt:FinancialYear1Member5436352026-08-182026-08-18in-capmkt:FinancialYear2Member5436352026-08-182026-08-18in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure543635Piramal Pharma LimitedPPLPHARMANOTLISTEDINE0DK501011NewAcquisition (including agreement to acquire)false2026-08-1810:05:002026-08-18Clarificatory notes: <BR> 1.The financial parameters of Yapan Bio Private Limited (the Target Company) mentioned herein for FY 2025-26 are based on unaudited financial statements. <BR> 2. The transaction is an additional investment through exercise of call option and is not a related party transaction. Accordingly, Row No. 24 (whether the transaction is at arm’s length) and Row No. 25 (whether a special resolution is passed) are Not Applicable. As the ‘N.A.’ option is not available in the XBRL file, ‘No’ has been selected for both rows.Piramal Pharma LimitedListed Entity (self)Yapan Bio Private Limited263400000-35300000797500000falsetrueThe promoter / promoter group of the Piramal Pharma Limited ('Company') is deemed to be indirectly interested in Yapan Bio Private Limited ('Yapan') through the Company’s investment therein.falsefalsePharmaceuticalWith this acquisition, the Company will fully embed Yapan's advanced large molecule capabilities into its integrated service offering, enabling the Company to develop and scale complex biologic therapies with greater efficiency.NofalseCompletedCash760000000Cash7600000000.33330.40670.74Yapan, incorporated on 11th October, 2019, under the provisions of Companies Act, 2013, is a Contract Development and Manufacturing Organization, specializing in process development, characterization and Phase I/II GMP manufacturing services for vaccines and biologics.2019-10-112025-20262634000002024-20255440000002023-2024269100000India